Related Experiment Video
Updated: Oct 13, 2025

09:38
Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
Published on: April 14, 2016
12.9K
Medical Cannabis Use and Pain: An Experience Sampling Study
Sharon Rodner Sznitman1, Dennis Rosenberg1, Simon Vulfsons2,3
1School of Public Health, University of Haifa, Haifa, Israel.
Frontiers in Psychiatry
|November 15, 2021
Summary
Chronic pain patients with long-term medical cannabis (MC) use intend to use MC when pain flares. However, this study found no evidence that MC use relieved pain, negative affect, or fatigue in daily life.
Area of Science:
- Pain Management
- Cannabis Therapeutics
- Behavioral Medicine
Background:
- Limited research exists on the long-term effects of medical cannabis (MC) on pain and associated symptoms outside controlled experimental settings.
- Existing studies often lack external validity, necessitating naturalistic research designs to understand real-world MC use in chronic pain (CP) patients.
- Understanding the relationship between pain and MC use patterns in daily life is crucial for effective CP management.
Purpose of the Study:
- To investigate the associations between momentary pain intensity, affect, fatigue, and medical cannabis (MC) use in chronic pain (CP) patients.
- To examine the relationship between the time since last MC use and subsequent experiences of pain, negative affect, and fatigue.
- To provide externally valid data on the long-term efficacy of MC for symptom management in a naturalistic setting.
Main Methods:
- A naturalistic daily diary study design was employed, collecting data three times daily over a 10-day period from 78 chronic pain patients using medical cannabis.
- A total of 1,688 observations were recorded, capturing momentary experiences of pain, affect, and fatigue.
- Mixed-effects models were utilized to analyze the within-person associations between medical cannabis use and reported symptoms.
Main Results:
- A significant association was found between elevated pain intensity and a greater intention to use medical cannabis (MC) within the subsequent hour.
- No statistically significant evidence emerged to suggest that the time elapsed since the last MC use was related to pain levels.
- Similarly, the time lapse since last MC use did not correlate with reported negative affect or fatigue levels.
Conclusions:
- Chronic pain patients with long-term medical cannabis (MC) use demonstrate an intention to use MC as a response to immediate pain experiences.
- The study did not find evidence supporting the efficacy of MC in providing immediate pain relief or reducing negative affect and fatigue in daily use.
- Further research is warranted to explore potential benefits of continued MC use, such as managing dependence, withdrawal symptoms, or improving general well-being, despite the lack of acute pain relief.
Related Concept Videos
Analgesia and Pain Management
927
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
927
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
416
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
416

